Raju Mohan Ph.D

Raju Mohan Ph.D General Information

Biography

Dr. Raju Mohan is the Founder and serves as Chief Executive Officer and as a member of our board of directors at Ventyx Biosciences. He is also a director and has served as the Chief Executive Officer of Escalier Biosciences B.V. and Vimalan Biosciences, Inc. since December 2016 and October 2017, respectively, and as a Partner and Scientific Advisor at New Science Ventures since 2017. He previously founded Akarna Therapeutics in October 2014 and served as its chief executive officer from its founding until it was acquired by Allergan in September 2016. In addition, he founded Oppilan Pharma Ltd. in May 2015 (acquired by us in February 2021), Zomagen Biosciences Ltd. in July 2018 (acquired by us in February 2021) and Vimalan Biosciences in October 2017, all immunology-focused specialty pharmaceutical companies. From 2006 to 2011, he served as Vice President and head of the San Diego site for Exelixis, Inc. From 2004 to 2006, he served as Vice President of Chemistry at X-Ceptor Therapeutics (acquired by Exelixis). He started his pharmaceutical career at Berlex Biosciences in 1987, a subsidiary of Bayer/Schering AG. He received a Ph.D. in Chemistry from the University of Illinois, Urbana-Champaign and a master's degree from the Indian Institute of Technology.